IFPMA 2015 interview series ‘Fake medicines: what are they? / Les faux médicaments: de quoi s’agit-ils?’
Share
Ms Cyntia Genolet, IFPMA’s Policy Analyst, Regulatory & Health Policy and leads the organisation’s anti-counterfeiting portfolio, together with Marc Gentilini, General Delegate of ‘Fondation Chirac’ give their take on what fake medicines are and how to curb their threat.
About IFPMA
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit ifpma.org.
Learn more
